4//SEC Filing
Oosthuizen Johannes Jacobus 4
Accession 0001127602-24-003352
CIK 0000310158other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:01 PM ET
Size
15.8 KB
Accession
0001127602-24-003352
Insider Transaction Report
Form 4
Oosthuizen Johannes Jacobus
President, U.S. Market
Transactions
- Exercise/Conversion
Common Stock
2024-02-02$75.36/sh+6,773$510,413→ 28,122.345 total - Exercise/Conversion
Common Stock
2024-02-02$87.10/sh+7,119$620,065→ 42,286.345 total - Sale
Common Stock
2024-02-02$127.17/sh−18,959$2,411,111→ 23,327.345 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−7,045→ 7,049 totalExercise: $73.73From: 2022-05-04Exp: 2031-05-03→ Common Stock (7,045 underlying) - Exercise/Conversion
Common Stock
2024-02-02$73.73/sh+7,045$519,428→ 35,167.345 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−7,119→ 14,240 totalExercise: $87.10From: 2023-05-03Exp: 2032-05-02→ Common Stock (7,119 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−6,773→ 0 totalExercise: $75.36From: 2021-05-01Exp: 2030-04-30→ Common Stock (6,773 underlying)
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]The option vested and became exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
- [F3]The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
- [F4]The option vests and becomes exercisable in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001916310
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:01 PM ET
- Size
- 15.8 KB